Handbook of Pharmaceutical Biotechnology / Edition 1

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $162.94
Usually ships in 1-2 business days
(Save 28%)
Other sellers (Hardcover)
  • All (8) from $162.94   
  • New (7) from $162.94   
  • Used (1) from $176.83   

Overview

This handbook describes the use of biotechnology to develop pharmaceuticals. The process of biotechnological drug development systematically identifies which protein is causing a problem in the body - either becasue it is absent, defective, or excessive - and then identifying and engineering a protein or related molecule to correct the problem. The Handbook of Pharmaceutical Biotechnology gives the professional a basic tool to facilitate the development of biotech medicines by bringing together, in one resource, a general but, not trivial, overview of biotechnology used in the drug development process, along with a compendium of regulations and validation methods that need to be considered when using biotech to develop a new drug.

Read More Show Less

Editorial Reviews

From the Publisher
"In summary, the Handbook of Pharmaceutical Biotechnoloyg is an invaluable addition to the bookshelf of any biopharmaceutical scientist. It is not only useful as a reference book, but also enjoyable to read as a textbook due to the topical and well-written subject matter. . . highly recommended." (Biochemist, 1 April 2011)

"I think this is an excellent book certainly the best of its kind I have come across." (BTS Newsletter, Summer 2008)

Read More Show Less

Product Details

  • ISBN-13: 9780471213864
  • Publisher: Wiley
  • Publication date: 6/15/2007
  • Series: Pharmaceutical Development Series, #2
  • Edition number: 1
  • Pages: 1680
  • Product dimensions: 7.32 (w) x 10.10 (h) x 2.23 (d)

Meet the Author

Shayne Cox GAD, PhD, DABT, ATS, is the Principal of Gad Consulting Services. He has more than thirty years of experience as a toxicologist, statistical consultant, manager, and consultant on research and development in the chemical, consumer product, contract testing, biotechnology, medical device, and pharmaceutical industries. He is the author of twenty-nine books, including Drug Discovery Handbook (Wiley), and numerous papers, presentations, and other publications.

Read More Show Less

Table of Contents

Preface.

1.1 From Gene to Product: The Advantage of Integrative Biotechnology (Frank-Ranier Schmidt).

1.2 Sequencing the Human Genome: Was It Worth It? (Eugene Zabarovsky).

1.3 Overview: Differentiating Issues in the Development of Macromolecules Compared with Small Molecules (Günther Blaich, Bernd Janssen, Gregory Roth, and Jochen Salfeld).

1.4 Integrated Development of Glycobiologics: From Discovery to Applications in the Design of Nanoparticular Drug Delivery Systems (Christine Vauthier, Isabelle Bertholon, and Denis Labarre).

1.5 R&D Paradigm Shift and Billion-Dollar Biologics (Krishan Maggon).

2 From Defi ning Bioinformatics and Pharmacogenomics to Developing Information-Based Medicine and Pharmacotyping in Health Care (Ioannis S. Vizirianakis).

3.1 Toxicogenomics (Mary Jane Cunningham and Mrinal Shah).

3.2 Preclinical Pharmacokinetics (Donald E. Mager and Murali Ramanthan).

3.3 Strategies for the Cytosolic Delivery of Macromolecules: An Overview (Aravind Asokan, Roland Cheung, and Moo J. Cho).

4.1 Basic Issues in the Manufacture of Macromoleucles (Corinne Lengsfeld and Thomas Anchordoquy).

4.2 Process Validation for Biopharmaceuticals (Beth Junker).

4.3 Stability Assessment and Formulation Characterization (Albert H.L. Chow, Henry H.Y. Tong, and Ying Zheng).

4.4 Protein Posttranslational Modifi cation: A Potential Target in Pharmaceutical Development (M.D. Mostaqul Huq and Li-Na Wei).

4.5 PEGylation: Camoufl age of Proteins, Cells, and Nanoparticles Against Recognition by the Body’s Defense Mechanism (Yong Woo Cho, Jae Hyung Park, Ji Sun Park, and Kinam Park).

4.6 Unexpected Benefi ts of a Formulation: Case Study with Erythropoetin (David Keast).

5.1 Capillary Separation Techniques (Dong Hee Na and Kang Choon Lee).

5.2 Pharmaceutical Bioassay (Jun Li, Ming Zhao, and Shiqi Peng).

5.3 Analytical Considerations for Immunoassays for Macromolecules (Marian Kelley and Binodh DeSilva).

5.4 Chromatography-Based Separation of Proteins, Peptides, and Amino Acids (Jan Moebius, Remco Swart, and Albert Sickman).

5.5 Bioanalytical Method Validation for Macromolecules (Gerhard K.E. Scriba).

5.6 Microarrays in Drug Discovery and Development (Krishnanand D. Kumble and Sarita Kumble).

5.7 Genetic Markers and Genotyping Analyses for Genetic Disease Studies (Anne E. Kwitek and Michael Olivier).

6.1 Proteins: Hormones, Enzymes, and Monoclonal\Antibodies—Background (Wayne Materi, Zoltan Gombos, and David S. Wishart).

6.2 Formulation and Delivery Issues of Therapeutic Proteins (Sathy V. Balu-Iyer, Razvan D. Miclea, and Vivek S. Purohit).

6.3 Pharmacokinetics (Nobuhito Shibata, Yukato Ito, and Kanji Takada).

6.4 Immunogenicity of Therapeutic Proteins (Suzanne Hermeling, Daan J.A. Crommelin, Huub Schellekens, and Wim Jiskoot).

6.5 Development and Characterization of High-Affi nity Anti-Topotecan IgG and Fab Fragments (Jin Chen and Joseph P. Balthasar).

6.6 Recombinant Antibodies for Pathogen Detection and Immunotherapy (Nicholas J. Pokorny, Jeanine I. Boulter-Bitzer, J. Chris Hall,Jack T. Trevors, and Hung Lee).

6.7 The Radiopharmaceutical Science of Monoclonal Antibodies and Peptides for Imaging and Targeted in situ Radiotherapy of Malignancies (Raymond M. Reilly).

7.1 Gene Therapy—Basic Principles and the Road from Bench to Bedside (Gabor M. Rubanyi).

7.2 Plasmid DNA and Messenger RNA for Therapy (Steve Pascolo).

7.3 Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies (Tatiana Segura).

7.4 Pharmacokinetics of Nucleic-Acid-Based Therapeutics (John C. Schmitz, Aleksandra Pandyra, James Koropatnick, and Randal. W. Berg).

7.5 Case Studies—Development of Oligonucleotides (Ezharul Hoque Chowdhury and Toshihiro Akaike).

7.6 RNA Interference: The Next Gene-Targeted Medicine (Andrew V. Oleinikov and Matthew D. Gray).

7.7 Delivery Systems for Peptides/Oligonucleotides and Lipophilic Nucleoside Analogs (R.A. Schwendener and Herbert Schott).

8.1 Growth Factors and Cytokines (Mandeep K. Mann and Brian E. Cairns).

8.2 Growth Factors, Cytokines, and Chemokines: Formulation, Delivery, and Pharmacokinetics (Heping Cao and Rui Lin).

9 Protein Engineering with Noncoded Amino Acids: Applications to Hirudin (Vincenzo De Filippis).

10.1 Production and Purifi cation of Adenovirus Vectors for Gene Therapy (D.M.F. Prazeres and J.A.L. Santos).

10.2 Assessing Gene Therapy by Molecular Imaging (Pascal Delepine and Claude Férec).

11 Overview of Stem and Artifi cial Cells (Alejandro Soto-Gutierrez, Nalu Navarro-Alvarez, Jorge David Rivas-Carrillo, and Naoya Kobayashi).

12.1 Regulation of Small-Molecule Drugs Versus Biologicals Versus Biotech Products (María de los Angeles Cortés Castillo and José Luis Di Fabio).

12.2 Intellectual Property and Biotechnology (Tania Bubela and Karen Lynne Durell).

12.3 Comparability Studies for Later-Generation Products—Plant-Made Pharmaceuticals (Patrick A. Stewart).

12.4 Biosimilars (H. Schellekens, W. Jiskoot, and D.J.A. Crommelin).

13.1 The Promise of Individualized Therapy (Michael Oettel).

13.2 Enhanced Proteomic Analysis by HPLC Prefractionation (Pierre C. Havugimana, Peter Wong, and Andrew Emili).

13.3 An Overview of Metabonomics Techniques and Applications (John C. Lindon).

13.4 Bioterrorism (Dany Shoham).

Index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)